Microfluidic Yeast Lifespan Screening via Daughter Cell Trapping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring replicative lifespan in yeast are labor-intensive and time-consuming, making it difficult to screen for anti-aging drugs and genetic mutations effectively.
Innovation Solution
A high-throughput system using microfluidic devices and a yeast cell daughter-arresting-program (DAP) that allows for the measurement of replicative lifespan by trapping and counting arrested daughter cells, eliminating the need for manual microdissection and enabling simultaneous testing of multiple strains or compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If manual micro-dissection is used to count daughter cells, then measurement precision is maintained, but productivity is extremely low and time consumption is high
Solution Approach 1:
The patent replaces manual mechanical micro-dissection with an automated microfluidic system that uses fluid flow and microstructured channels to separate and count daughter cells. The microfluidic device uses pressure-driven flow and geometric constraints to automatically isolate daughter cells from mother cells, eliminating the need for manual manipulation while maintaining measurement accuracy and dramatically increasing throughput.
Solution Approach 2:
The microfluidic system performs self-automation where the device structure itself enables the separation and counting processes without external manual intervention. The microstructured channels and flow conditions are designed to automatically separate daughter cells from mother cells based on their size differences, and the system self-regulates the counting process through integrated detection mechanisms.
2Measurement precision
If traditional lifespan assay methods are used, then measurement precision is maintained, but loss of time is excessive making large-scale screening impractical
Solution Approach 1:
The microfluidic system enables continuous monitoring and counting of daughter cells throughout the entire replicative lifespan of mother cells. Instead of discrete manual interventions at each time point, the system continuously maintains culture conditions, automatically separates cells, and counts daughter cells at multiple time points simultaneously, providing continuous data acquisition that accelerates screening while maintaining precision.
Solution Approach 2:
The patent transitions from single-cell manual analysis to multi-cell parallel analysis by adding the dimension of parallel processing. The microfluidic device can simultaneously culture and analyze multiple mother cells in parallel across different channels, and the system can process multiple time points concurrently, effectively adding temporal and spatial dimensions to the measurement process that dramatically reduce total screening time.
3Ease of operation
If manual micro-dissection is used, then ease of operation is maintained at basic level, but device complexity increases when scaling to high-throughput
Solution Approach 1:
The microfluidic device is segmented into multiple independent functional modules including culture chambers, separation channels, detection zones, and data processing units. Each module performs a specific function and can be independently optimized or replaced. This modular segmentation allows the system to maintain operational simplicity at the user level while managing the underlying complexity through standardized, interchangeable components.
Data Source
AI summary
Compositions, devices, and systems for use in a high-throughput screening platform for identifying anti-aging compounds and/or mutations that extend replicative life span (RLS). Specifically, herein disclosed is a yeast cell daughter-arresting-program (DAP), as well as compositions used in devices and systems that allow measurement of replicative lifespan and identification of agents or mutations that modulate the lifespan.


